摘要
目的:检测乳腺癌患者外周血、肿瘤组织中hSTC-1mRNA的表达,判断外周血微转移状况,探讨微转移与肿瘤恶性程度之间的关系。方法:采用RT-PCR法检测乳腺癌组织、外周血中hSTC-1的mRNA表达,用免疫组化法检测乳腺肿瘤组织中ER、PR及VEGF的表达。结果:hSTC-1mRNA在乳腺癌患者癌组织中的阳性率为93.3%(28/30),在外周血中的阳性率为37.3%(19/51);17例非肿瘤成年女性患者外周血中未检测到hSTC-1的mRNA。血液中的hSTC-1的mRNA表达与多个临床病理因子有相关性(P<0.05),包括:肿瘤大小、腋淋巴结转移、TNM分期、ER、VEGF等;结论:乳腺癌患者外周血检测到hSTC-1基因的表达,说明乳腺癌已发生血行微转移,乳腺癌患者外周血hSTC-1的mRNA表达与多个临床病理因子有关;这些因子决定乳腺癌的预后,因此hSTC-1可以作为检测乳腺癌外周血微转移的一种新的分子标记。
Objective :To detect the expression of human stanniocalcin-1 ( hSTC-1 ) mRNA in peripheral blood and tumor tissues of breast cancer patients, determine micrometastases in peripheral blood, and study the relationship between the micrometastases and malignant degree of breast cancer. Methods: The expression of hSTC-1 mRNA in peripheral blood and breast cancer tissues was detected by RT-PCR. The expression of estrogen receptor (ER), progesterone receptor (PR), and vascular endothelial growth factor (VEGF) in breast cancer tissues were detected by immunohistochemical method. Results: Expression of hSTC-1 mRNA was identified in breast cancer tissues from 28 of 30 patients (93.3%) and in peripheral blood from 19 of Sl patients (37.3%). Expression of hSTC-1 mRNA was not detected in the peripheral blood from 17 women without breast cancer. Expression of hSTC-1 mRNA in the peripheral blood significantly correlated with multiple clinicopathological factors ( P 〈 0.05 ), including tumor size, metastasis of lymph nodes, TNM stage, and the expression of ER and VEGF. Conclusion: The expression of hSTC-1 mRNA in the peripheral blood of breast cancer patients suggests the occurrence of micrometastasis. It significantly correlates with multiple clinicopathological factors which determined the prog- nosis of breast cancer. So hSTC-1 is proposed as a new marker for detecting micrometastasis of breast cancer in the peripheral blood.
出处
《肿瘤》
CAS
CSCD
北大核心
2007年第12期977-980,共4页
Tumor
基金
南通市科技局资助项目(编号:S5052)
关键词
乳腺肿瘤
肿瘤转移
反转录聚合酶链反应
人类斯钙素-1
Breast neoplasms
Metastasis
Reverse transcriptase polymerase chain reaction
Human stanniocalcin-1